AstraZeneca PLCAZNNASDAQ
Loading
Price to Sales HistoryNormalizing
Percentile Rank93
3Y CAGR+1.1%
5Y CAGR+1.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+1.1%/yr
vs +1.2%/yr prior
5Y CAGR
+1.8%/yr
Consistent
Acceleration
-0.2pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.90 | +27.7% |
| 2024 | 3.83 | -15.3% |
| 2023 | 4.52 | -4.6% |
| 2022 | 4.74 | +5.7% |
| 2021 | 4.49 | +0.1% |
| 2020 | 4.48 | -16.2% |
| 2019 | 5.35 | +18.5% |
| 2018 | 4.52 | +21.0% |
| 2017 | 3.73 | +12.9% |
| 2016 | 3.31 | - |